VPIM
LKFT

Vanguard Personalized Indexing Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,106
Closed -$212K – 2011
2025
Q3 		$212K Buy
+6,106
New +$195K ﹤0.01% 1679
2025
Q1 		– Sell
-9,257
Closed -$255K – 1873
2024
Q4 		$255K Buy
+9,257
New +$258K ﹤0.01% 1411

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Personalized Indexing Management's LKFT Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 6,106 shares — an estimated $212K sold.

Vanguard Personalized Indexing Management first reported a position in LKFT in Q4 2024 and held it in 2 quarters. The position peaked at $255K in Q4 2024. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 6,106 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $212K.
  • Vanguard Personalized Indexing Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2024 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $255K in Q4 2024.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.